[HTML][HTML] Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease

MN Hoque, A Chaudhury, MAM Akanda, MA Hossain… - PeerJ, 2020 - peerj.com
Abstract The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic
viral infection caused by a novel evolutionarily divergent RNA virus, the severe acute …

[HTML][HTML] Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity

MR Islam, MN Hoque, MS Rahman, ASMRU Alam… - Scientific reports, 2020 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel evolutionary
divergent RNA virus, is responsible for the present devastating COVID-19 pandemic. To …

Potential drug targets of SARS-CoV-2: From genomics to therapeutics

A Shamsi, T Mohammad, S Anwar, S Amani… - International Journal of …, 2021 - Elsevier
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from
China has become a global threat due to the continuous rise in cases of Coronavirus …

An overview of basic molecular biology of SARS-CoV-2 and current COVID-19 prevention strategies

A Das, R Ahmed, S Akhtar, K Begum, S Banu - Gene reports, 2021 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) manifests as extreme acute respiratory
conditions caused by a novel beta coronavirus named severe acute respiratory syndrome …

[HTML][HTML] Genomic epidemiology and recent update on nucleic acid–based diagnostics for COVID-19

AA Rabaan, SH Al-Ahmed, R Sah, JA Al-Tawfiq… - … tropical medicine reports, 2020 - Springer
Abstract Purpose of the Review The SARS-CoV-2 genome has been sequenced and the
data is made available in the public domain. Molecular epidemiological investigators have …

The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options

A Asghari, M Naseri, H Safari, E Saboory… - DNA and Cell …, 2020 - liebertpub.com
On December 31, 2019, a novel coronavirus, being the third highly infective CoV and named
as coronavirus disease 2019 (COVID-19) in the city of Wuhan, was announced by the World …

Novel SARS-CoV-2/COVID-19: Origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis

Y Junejo, M Ozaslan, M Safdar, RA Khailany… - Gene reports, 2020 - Elsevier
In this review, we focused on the origins of the novel coronavirus (SARS-CoV-2), origin,
pathogenesis, immune responses, genes and genetic variations, phylogenetic analyses …

Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially …

R Sardar, D Satish, S Birla, D Gupta - BioRxiv, 2020 - biorxiv.org
The ongoing pandemic of the coronavirus disease 2019 (COVID-19) is an infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). We have …

[HTML][HTML] Approaches towards fighting the COVID‑19 pandemic

SC Tsai, CC Lu, DT Bau, YJ Chiu… - International …, 2021 - spandidos-publications.com
Abstract The coronavirus disease 2019 (COVID‑19) outbreak, which has caused> 46
millions confirmed infections and> 1.2 million coronavirus related deaths, is one of the most …

[HTML][HTML] SARS-CoV-2: from its discovery to genome structure, transcription, and replication

AC Brant, W Tian, V Majerciak, W Yang, ZM Zheng - Cell & bioscience, 2021 - Springer
SARS-CoV-2 is an extremely contagious respiratory virus causing adult atypical pneumonia
COVID-19 with severe acute respiratory syndrome (SARS). SARS-CoV-2 has a single …